Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Xencor, Inc. on the deal. Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
